Search

everythinglearnresearchcommunity

for

Search:↓

Most skin issues were due to COVID-19, with some caused by vaccines or treatments, and were categorized into five types.

Alopecia areata treatment should be personalized, using topical or systemic therapies based on severity, with promising options like JAK inhibitors needing more research.

Alopecia areata is a hair loss condition caused by immune factors and can be treated with JAK inhibitors.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Disrupted cholesterol production impairs hair follicle stem cells, leading to hair loss.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Linagliptin may cause hair loss and skin blisters.

Vitiligo is a skin condition causing white spots, more common in women, often starts before age 20, and can affect mental health.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Current treatments for alopecia show no significant long-term benefits.

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

Fractional laser therapy may help regrow hair in alopecia areata.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Eyelash alopecia areata often goes undiagnosed and can lead to complete eyelash regrowth, especially in younger patients.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Treatments for autoimmune hair loss have limited success and often relapse, and emotional support is crucial for those affected.

Treatments for autoimmune hair loss have limited success and patients need emotional support and self-acceptance.

Steroids help hair regrowth, and minoxidil slows post-steroid hair loss, but effects are temporary.

PRP more effective than minoxidil 5% for treating alopecia areata.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Alopecia areata is an autoimmune condition causing hair loss, linked to genetic factors and immune system issues, with no cure yet.

RDW can be a useful marker for inflammation in alopecia areata patients.

Most treatments for Frontal Fibrosing Alopecia are ineffective, but early anti-inflammatory therapy may help and the condition may stabilize over time.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.